Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: A multicenter open-label single-arm trial in Korean patients

Author:

Heo Kyoung,Lee Byung In,Yi Sang Do,Cho Yong Won,Shin Dong Jin,Song Hong Ki,Kim Ok Joon,Park Sung-Pa,Kim Sung Eun,Kim Sang Ho,Lee Jun Hong,Kim Kyu-Sik,Lee Se-Jin

Funder

Eisai Korea Inc.

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference23 articles.

1. The neurobiology of antiepileptic drugs;Rogawski;Nat Rev Neurosci,2004

2. Zonisamide. Chemistry, biotransformation, and pharmacokinetics;Shah,2002

3. Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures;Kochak;J Clin Pharmacol,1998

4. Clinical pharmacology and therapeutic drug monitoring of zonisamide;Mimaki;Ther Drug Monit,1998

5. Pharmacokinetics and drug interactions with zonisamide;Sills;Epilepsia,2007

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3